Table 1.

The clinicopathological features of the entire group of patients (N = 61)

Factor
Age, years (mean ± SD)		48.0 ± 9.8
Menopausal status, n (%)	Pre	27	44.30
	Post	34	55.70
Body mass index (BMI), n (%)	Low	11	18.00
	High	50	82.00
Family history, n (%)	No	55	90.20
	Yes	6	9.80
Diabetes mellitus (DM), n (%)	No	52	85.20
	Yes	9	14.80
Pathological subtypes, n (%)	IDC	40	65.60
	IL	14	23.00
	Others	7	11.50
Grade, n (%)	1	4	6.60
	2	29	47.50
	3	28	45.90
Capsular invasion, n (%)	No	35	57.40
	Yes	26	42.60
ER, n (%)	Negative	26	42.60
	Positive	35	57.40
PR, n (%)	Negative	31	50.80
	Positive	30	49.20
HER2, n (%)	Negative	44	72.10
	Positive	17	27.90
Ki-67, n (%)	Low	44	72.10
	High	17	27.90
Molecular subtypes, n (%)	Luminal A	24	39.30
	Luminal B	11	18.00
	HER2 amplified	14	23.00
	Triple –ve	12	19.70
T, n (%)	0	2	3.30
	1	8	13.10
	2	9	14.80
	3	23	37.70
	4	17	27.90
N, n (%)	0	10	16.40
	1	17	27.90
	2	5	8.20
	3	29	47.50
Stage, n (%)	Stage I	4	6.60
	Stage II	13	21.30
	Stage III	29	47.50
	Stage IV	15	24.60
M, n (%)	No	46	75.40
	Yes	15	24.60